Revance Therapeutics, Inc. Quarterly Goodwill in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Revance Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2019 to Q4 2023.
  • Revance Therapeutics, Inc. Goodwill for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$77.2M -100% Dec 31, 2023 10-K 2024-02-28
Q3 2023 $0 -$147M -100% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $77.2M -$69.8M -47.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $77.2M -$69.8M -47.5% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $77.2M -$69.8M -47.5% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $147M $0 0% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $147M $0 0% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $147M $0 0% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $147M $0 0% Dec 31, 2021 10-K 2024-02-28
Q3 2021 $147M +$2.46M +1.7% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $147M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $147M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $147M +$147M Dec 31, 2020 10-K 2022-02-28
Q3 2020 $145M Sep 30, 2020 10-Q 2020-11-09
Q4 2019 $0 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.